[Tisserand & Young 2014] Essential Oil Safety: A Guide for Health Care Professionals, 2nd ed., Churchill Livingstone Elsevier (B216, p.823–824). Primary clinical safety source.
[Lawrence, B. M.] Mentha cardiaca + Mentha spicata var. crispa chemistry sources, p.200 per B216 p.823.
[Council of Europe] ADI 1 mg/kg carvone (isomer not specified) — basis for max oral 90–115 mg/d adult derivation.
[IFRA 2009] carvone leave-on body-lotion 1.2% cap for skin sensitization — basis for T&Y 1.7% dermal derivation.
[B216 Chapter 14 — Carvone profile] class-mechanism source for dermal + oral derivations.
[Opdyke, D. L. J.] spearmint oil acute toxicity + non-phototoxicity 4%/25 volunteers clinical-clean (p.871–872).
[Frosch, P. J., et al] patch-test dermatitis-patient cohort 13/1606 (0.8%) at 2% spearmint oil.
[Paulsen, E., Andersen, K. E.] patch-test cohort 5/318 (1.6%) at 2% spearmint oil.
[Larsen, W., et al] patch-test fragrance-sensitive cohort 9/178 (5.0%) at 5% spearmint oil.
[Manosroi, J., et al] chemopreventive activity KB + P388 cell lines IC50 65 + 61 µg/mL.
[Zu, Y., et al] M. spicata prostate cancer cell IC50 0.09%.
[Lam, L. K. T., Zheng, B. L.] spearmint glutathione S-transferase induction mouse tissue.
[Ishidate, M., et al] Ames + CA test non-mutagenic.
[Hayashi, M., et al] mouse micronucleus non-genotoxic.
[Bonamonte, D., et al] 64-yo woman allergic-lesion case report.
[Skrebova, N., et al] oral-lesion / stomatitis case reports.
[Farley, D. R., Howland, V.] (1R)-(+)-β-pulegone occasional trace ≤1.0%.
[Burfield, T.] adulteration with added (−)-carvone.
[Kubeczka, K.-H.] commercial production geography.
[APG-IV] Lamiaceae family + Lamiales order taxonomy.